![press-release-sabinsa](https://sabinsa.com/images/newsroom/press-releases/sami-sabinsa-patents-thumb.jpg)
Sabinsa Reaches Intellectual Property Milestone with over 300 Patents Granted
Sabinsa’s intellectual property portfolio now includes 308 separate patents granted across the world. The most recent patents…
![press-release-sabinsa](https://sabinsa.com/images/Banners-2021/June/ecocert-cosmos-approved.jpg)
Sabinsa Cosmeceutical Ingredients COSMOS Approved: Cococin™, Saberry®, and Nigellin® Amber
Sabinsa has successfully completed the audit for several of its natural cosmetic ingredients as conforming to COSMOS standards…
![press-release-sabinsa](https://www.sabinsa.com/images/Banners_2020/july/curcumin-and-bioperine-thumb.jpg)
Research Published on Sabinsa's Curcumin C3 Complex®/BioPerine® Combination as Adjuvant Therapy in COVID-19 Patients
Sabinsa's flagship combination product, Curcumin C3 Complex® with BioPerine® (525mg/2.5 mg twice a day, 14 days), was used as adjuvant therapy for COVID-19 in a double-blind…
![press-release-sabinsa](https://sabinsa.com/images/Banners-2021/June/sabinsa_litigation.jpg)
Court Orders Prakruti to Pay over $1 Million in Fees and Costs to Sabinsa as a Sanction For Discovery Abuses in Litigation
Sami-Sabinsa Group Limited, the world leader in Curcumin for the dietary supplements industry, has been awarded more than $1 Million in attorney’s fees and costs against Prakruti Products…
![press-release-sabinsa](https://sabinsa.com/images/awards/2021/june/honarary-award-2021.jpg)
Sabinsa Founder Dr. Muhammed Majeed Named Father of Indian Nutraceuticals Industry by ASSOCHAM
Dr. Muhammed Majeed, founder of the Sami-Sabinsa Group, was named the Father of Indian Nutraceuticals Industry with an honorary award presented on the occasion of ASSOCHAM…
![press-release-sabinsa](https://sabinsa.com/images/Banners-2021/Jan/c3-reduct-oral-care-thumb.jpg)
New Research Published on Sabinsa’s Curcumin C3 Reduct® Supports Efficacy as an Oral Care Ingredient
New research has recently been published that builds upon evidence from a previous trial investigating the potential of Sabinsa’s Curcumin C3 Reduct®…
![press-release-sabinsa](https://sabinsa.com/images/Banners-2021/Jan/dr-kalyanam-presentation-thumb.jpg)
Sabinsa Top Scientist Gives Presentation to U.S. FDA
Dr. Kalyanam Nagabhushanam, President (R&D), Sabinsa Corporation presented, at the invitation of FDA…